Scholar Rock
Clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Learn more
Launch date
Employees
Market cap
€601m
Enterprise valuation
€490m (Public information from Sep 2024)
Share price
$8.27 SRRK
Cambridge Massachusetts (HQ)
Authorizing premium user...